Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens

Journal of Thrombosis and Haemostasis : JTH
P W CollinsB M Ewenstein

Abstract

Prophylactic factor (F)VIII has been shown to reduce bleeds and arthropathy in patients with severe hemophilia A. Assuming that the trough FVIII level is an important determinant of the efficacy of prophylaxis, this paper addresses the effect of the inter-patient variability in pharmacokinetics and different dosing regimens on trough levels. Simulations used FVIII half-lives and in vivo recoveries (IVR), observed during clinical trials with Advate [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method], and commonly used prophylactic regimens to calculate their effect on FVIII levels during prophylaxis. Half-life and dose frequency had a larger effect on trough FVIII and time per week with FVIII<1 IU dL(-1) than IVR and infused dose per kg. The combined effect of these parameters resulted in substantial inter-patient variability in the amount of FVIII required to sustain a desired trough level. Prophylactic regimens based on Monday, Wednesday, Friday dosing were less cost effective in maintaining a desired trough level throughout the week. Dose escalation on Friday to cover the weekend would require potentially harmful doses of FVIII in many patients, especially in young children where more than 50% would require a Fr...Continue Reading

References

Jul 1, 1992·Journal of Internal Medicine·I M NilssonH Pettersson
Jan 1, 1988·European Journal of Clinical Pharmacology·A MessoriP Rossi Ferrini
Oct 1, 1993·European Journal of Haematology·M CarlssonK Lindvall
Mar 22, 2001·Haemophilia : the Official Journal of the World Federation of Hemophilia·S BjörkmanE Berntorp
Nov 2, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·K FischerH M van den Berg
Apr 24, 2003·Haemophilia : the Official Journal of the World Federation of Hemophilia·S Björkman
Sep 11, 2004·Haemophilia : the Official Journal of the World Federation of Hemophilia·M D TarantinoUNKNOWN RAHF-PFM Clinical Study Group
Dec 1, 2004·Haemophilia : the Official Journal of the World Federation of Hemophilia·J AhnströmS Björkman
Jan 11, 2007·Haemophilia : the Official Journal of the World Federation of Hemophilia·S BjörkmanE Berntorp
Sep 22, 2007·Haemophilia : the Official Journal of the World Federation of Hemophilia·C R M Hay
Aug 10, 2007·The New England Journal of Medicine·Marilyn J Manco-JohnsonBruce L Evatt
May 28, 2008·Journal of Thrombosis and Haemostasis : JTH·V S BlanchetteUNKNOWN rAHF-PFM Clinical Study Group
Aug 21, 2008·Haemophilia : the Official Journal of the World Federation of Hemophilia·I E M den UijlI Plug
Jan 16, 2009·Journal of Thrombosis and Haemostasis : JTH·P W CollinsUNKNOWN rAHF-PFM Study Group
Apr 1, 1997·Haemophilia : the Official Journal of the World Federation of Hemophilia·M CarlssonR Ljung

❮ Previous
Next ❯

Citations

Mar 25, 2014·Orphanet Journal of Rare Diseases·Séverine HenrardNiko Speybroeck
Apr 15, 2014·Drug Design, Development and Therapy·Maria Elisa Mancuso, Pier Mannuccio Mannucci
Aug 22, 2015·Current Medical Research and Opinion·S A BrownS Dunkley
Feb 13, 2016·Haemophilia : the Official Journal of the World Federation of Hemophilia·E BerntorpS Lethagen
Nov 28, 2015·Haemophilia : the Official Journal of the World Federation of Hemophilia·J LockUNKNOWN 'OPTI-CLOT' study group
Nov 19, 2013·Pediatric Clinics of North America·Riten Kumar, Manuel Carcao
Jan 26, 2016·Seminars in Hematology·Manuel Carcao, Alok Srivastava
Jan 26, 2016·Seminars in Hematology·Meera Chitlur, Guy Young
Mar 2, 2016·Haemophilia : the Official Journal of the World Federation of Hemophilia·L A ValentinoG Spotts
Oct 3, 2014·Thrombosis and Haemostasis·Pier Mannuccio Mannucci
Jun 12, 2012·Haemophilia : the Official Journal of the World Federation of Hemophilia·K LindvallE Berntorp
Oct 31, 2012·Haemophilia : the Official Journal of the World Federation of Hemophilia·J TeitelJ Wu
Mar 29, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·A FarrugiaS Balboni
Mar 6, 2012·American Journal of Hematology·Steven W Pipe
Jun 21, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·B EwensteinM Alai
May 29, 2012·Journal of Thrombosis and Haemostasis : JTH·M E GorczycaA Srivastava
Oct 30, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·E Berntorp
Oct 31, 2012·Pediatric Blood & Cancer·Chris Barnes
Jun 29, 2012·Haemophilia : the Official Journal of the World Federation of Hemophilia·P W Collins
Jul 7, 2011·Journal of Thrombosis and Haemostasis : JTH·S HenrardC Hermans
Aug 23, 2011·Journal of Thrombosis and Haemostasis : JTH·B VerbruggenP Meijer
Apr 17, 2012·Haemophilia : the Official Journal of the World Federation of Hemophilia·A E PastoftB Lauritzen
Apr 10, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·L A Valentino
Sep 14, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·E R van BladelR E G Schutgens
May 28, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·J LockM H Cnossen
Feb 17, 2015·Haemophilia : the Official Journal of the World Federation of Hemophilia·N A DuncanA D Shapiro
Mar 31, 2015·British Journal of Haematology·Rolf Ljung, Nadine Gretenkort Andersson
Jan 15, 2015·Haemophilia : the Official Journal of the World Federation of Hemophilia·S KepaI Pabinger
Sep 10, 2015·European Journal of Haematology·Cedric HermansBrian O'Mahony
Apr 14, 2016·Expert Review of Pharmacoeconomics & Outcomes Research·Alessandro GringeriArmin J Reininger
Nov 4, 2015·Wiener klinische Wochenschrift·Ingrid PabingerChristoph Male
Aug 20, 2016·Expert Opinion on Drug Metabolism & Toxicology·Alanna McEneny-KingAndrea N Edginton
Sep 30, 2016·Expert Opinion on Drug Metabolism & Toxicology·Massimo Morfini
Oct 22, 2016·Thrombosis Journal·Rolf Ljung
Nov 5, 2016·Expert Review of Hematology·Muhlis Cem ArTeoman Soysal
Mar 25, 2017·Journal of Clinical Medicine·Massimo Morfini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Blood
Francesco RodeghieroAlberto Tosetto
Haemophilia : the Official Journal of the World Federation of Hemophilia
S L Meeks, T C Abshire
Haemophilia : the Official Journal of the World Federation of Hemophilia
Angelika BatorovaEuropean Haemophilia Treatment Standardisation Board
British Journal of Haematology
E A ChalmersPaediatric Working Party of United Kingdom Haemophilia Doctors' Organization
© 2022 Meta ULC. All rights reserved